First Manhattan’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,500
| Closed | -$106K | – | 1169 |
|
|
2024
Q1 | $106K | Sell |
3,500
-5
| -0.1% | -$152 | ﹤0.01% | 760 |
|
|
2023
Q4 | $98.5K | Buy |
3,505
+5
| +0.1% | +$140 | ﹤0.01% | 759 |
|
|
2023
Q3 | $95K | Hold |
3,500
| – | – | ﹤0.01% | 769 |
|
|
2023
Q2 | $108K | Hold |
3,500
| – | – | ﹤0.01% | 751 |
|
|
2023
Q1 | $126K | Sell |
3,500
-200
| -5% | -$7.21K | ﹤0.01% | 760 |
|
|
2022
Q4 | $146K | Hold |
3,700
| – | – | ﹤0.01% | 759 |
|
|
2022
Q3 | $148K | Hold |
3,700
| – | – | ﹤0.01% | 742 |
|
|
2022
Q2 | $155K | Hold |
3,700
| – | – | ﹤0.01% | 758 |
|
|
2022
Q1 | $144K | Hold |
3,700
| – | – | ﹤0.01% | 816 |
|
|
2021
Q4 | $147K | Hold |
3,700
| – | – | ﹤0.01% | 806 |
|
|
2021
Q3 | $133K | Hold |
3,700
| – | – | ﹤0.01% | 817 |
|
|
2021
Q2 | $151K | Hold |
3,700
| – | – | ﹤0.01% | 784 |
|
|
2021
Q1 | $161K | Buy |
3,700
+200
| +6% | +$8.7K | ﹤0.01% | 745 |
|
|
2020
Q4 | $175K | Buy |
+3,500
| New | +$175K | ﹤0.01% | 684 |
|